Provided by Tiger Fintech (Singapore) Pte. Ltd.

Gossamer Bio Inc.

0.8130
-0.0295-3.50%
Post-market: 0.8030-0.0100-1.23%19:43 EDT
Volume:1.60M
Turnover:1.31M
Market Cap:184.73M
PE:-3.25
High:0.8519
Open:0.8519
Low:0.8000
Close:0.8425
Loading ...

Gossamer Bio Inc expected to post a loss of 17 cents a share - Earnings Preview

Reuters
·
28 Feb

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
08 Feb

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Business Wire
·
08 Feb

Gossamer Bio Presented Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress

Business Wire
·
03 Feb

Gossamer Bio And 2 Other Promising Penny Stocks On US Exchanges

Simply Wall St.
·
30 Jan

Gossamer Bio Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
30 Jan

Gossamer Bio to Present Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress

Business Wire
·
28 Jan

BRIEF-Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
08 Jan

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
08 Jan

Why Gossamer Bio, Inc. (GOSS) Is Among the Best Penny Stocks to Invest In According to Media?

Insider Monkey
·
07 Jan

Gossamer Bio (GOSS) Upgraded to Buy: Here's What You Should Know

Zacks
·
27 Dec 2024

US Penny Stocks: 3 Picks With Market Caps Under $200M

Simply Wall St.
·
03 Dec 2024

All You Need to Know About Gossamer Bio (GOSS) Rating Upgrade to Buy

Zacks
·
22 Nov 2024

After Plunging -15.92% in 4 Weeks, Here's Why the Trend Might Reverse for Gossamer Bio (GOSS)

Zacks
·
14 Nov 2024

BUZZ-Cautious uptake of Merck's Winrevair gives opportunity to rivals, Oppenheimer says

Reuters
·
14 Nov 2024

Industry Analysts Just Made A Sizeable Upgrade To Their Gossamer Bio, Inc. (NASDAQ:GOSS) Revenue Forecasts

Simply Wall St.
·
12 Nov 2024

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
12 Nov 2024

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Business Wire
·
12 Nov 2024

Gossamer Bio Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
11 Nov 2024

Gossamer Bio, Inc. (NASDAQ:GOSS) Just Reported And Analysts Have Been Lifting Their Price Targets

Simply Wall St.
·
10 Nov 2024